26 Jul Viralgen
Andy Holt, Chief Commercial Officer
Oct. 7 | 11:00am | FLW Ballroom G
San Sebastian, Spain
(Private)
Viralgen is a CDMO that supports development through large-scale commercial production of cGMP certified AAV for cell and gene therapies. Through our proprietary Pro10™ suspension manufacturing platform, we deliver industry-leading titers for all AAV serotypes to our client partners, optimizing speed to market and cost-of-goods to accelerate clinical development and commercialization. The company’s state-of-the-art facilities based in San Sebastian, Spain include a commercial facility consisting of three modules, each having three cGMP suites with capacities of >2,000 L. Leveraging their proven expertise in AAVs, Viralgen has recently launched development services offerings focused on construct optimization, process optimization and right-sized scaling for customers needing additional support with their programs.
